Reauthorization of the Prescription Drug User Fee Act and FDA reform
by United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment.

No description available.
ManagementDrugsLaw and legislationUnited StatesPricesPrescription pricingUnited States. Food and Drug AdministrationDrugs, law and legislationDrugs, pricesUnited states, food and drug administration